Effectiveness and safety of bevacizumab in extensive-disease small cell lung cancer: a systemic review and meta-analysis

BACKGROUND: Small cell lung cancer (SCLC) is highly invasive and poorly prognostic. The effects of chemotherapy with bevacizumab are promising on other tumors but unclear in extensive-disease SCLC (ED-SCLC). A systemic review and meta-analysis were performed to investigate the efficacy and toxicity...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jiaxi, Pan, Hui, He, Jianxing, Li, Shuben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422128/
https://www.ncbi.nlm.nih.gov/pubmed/34532422
http://dx.doi.org/10.21037/atm-21-963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422128/
https://www.ncbi.nlm.nih.gov/pubmed/34532422
http://dx.doi.org/10.21037/atm-21-963

Ejemplares similares